These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 600197)

  • 41. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
    Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
    Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
    Block CS; Fabian B; Robinson RG
    S Afr Med J; 1978 Mar; 53(11):396-99. PubMed ID: 675374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Activity of various semisynthetic aminoglycoside antibiotics on gentamicin-sensitive and gentamicin-resistant bacterial populations].
    Zemelman R; Bello H; Mondaca MA
    Rev Med Chil; 1983 Mar; 111(3):255-61. PubMed ID: 6648106
    [No Abstract]   [Full Text] [Related]  

  • 44. Gentamicin and tobramycin--an in vitro comparison using 1400 clinical isolates.
    Forgan-Smith WR; Andrew JH; McSweeney RJ
    Pathology; 1976 Jul; 8(3):195-9. PubMed ID: 826868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of combinations of clindamycin with gentamicin, tobramycin, and amikacin against Staphylococcus aureus.
    Watanakunakorn C; Glotzbecker C
    J Antimicrob Chemother; 1980 Nov; 6(6):785-91. PubMed ID: 7440469
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sensitivity in vitro of 192 Proteus strains to several aminoglycosides].
    Thaller MC; Berchicchi R; Berlutti F; Maragoni F; Dainelli B
    Ann Sclavo; 1981; 23(1):57-63. PubMed ID: 7294918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
    Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K
    Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitivity of gram-negative bacteria to six aminoglycoside antibiotics.
    Eyckmans L; Beert J
    Infection; 1977; 5(1):9-12. PubMed ID: 404254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Topical and microbiological evaluation of dideoxykanamycin B in comparison to other second and third generation aminoglycosides].
    Nicoletti G; Russo G; Toscano MA; Gismondo MR; Mattina R
    G Ital Chemioter; 1979; 26(1-2):167-72. PubMed ID: 554806
    [No Abstract]   [Full Text] [Related]  

  • 51. Susceptibility of some Staphylococcus species to aminoglycosides.
    Geraci C; Stefani S; Focà A; Stassi G; Varaldo PE; Cipriani P; Giordano A
    Chemioterapia; 1985 Dec; 4(6):436-8. PubMed ID: 3854285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-vitro efficacy of cefotiam in combination with four aminoglycosides on staphylococci and Gram-negative bacteria.
    Daschner FD; Steffens A; Schneider H
    J Antimicrob Chemother; 1981 Sep; 8(3):239-41. PubMed ID: 6270053
    [No Abstract]   [Full Text] [Related]  

  • 53. [New aminoglycoside desoxystreptamine-containing antibiotics].
    Gol'dberg LE
    Antibiotiki; 1976 Nov; 21(11):1033-50. PubMed ID: 65938
    [No Abstract]   [Full Text] [Related]  

  • 54. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé
    Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
    [No Abstract]   [Full Text] [Related]  

  • 55. 3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.
    Barry AL; Jones RN; Thornsberry C; Gavan TL; Gerlach EH; Sommer HM
    Eur J Clin Microbiol; 1984 Dec; 3(6):531-7. PubMed ID: 6441709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
    Brewer NS
    Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium.
    Vanhoof R; Hubrechts JM; Nyssen HJ; Roebben E
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):183-5. PubMed ID: 3134209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984.
    Bengtsson S; Bernander S; Brorson JE; Dornbusch K; Forsgren A; Hallander H; Henning C; Holm S; Malmborg AS; Nilsson L
    Scand J Infect Dis; 1986; 18(3):257-63. PubMed ID: 3738436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The new aminoglycoside antibiotics.
    Fields BT
    J Ark Med Soc; 1976 Aug; 73(3):141-4. PubMed ID: 134018
    [No Abstract]   [Full Text] [Related]  

  • 60. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
    Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.